Position in ACAD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$7,912,561
-$1,732,046 QoQ
Shares Held
355,461
-1.6% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 45.6187879964328.ToString("F0")%
Shared 0.ToString("F0")%
None 54.3812120035672.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. ACAD ranks #29 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in ACAD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,912,561 | 355,461 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $9,644,607 | 361,086 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,355,655 | 391,549 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $7,918,045 | 367,086 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,858,612 | 352,716 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $3,220,938 | 175,528 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,739,808 | 178,141 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,030,625 | 186,500 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,409,167 | 184,379 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,738,622 | 183,284 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,842,896 | 184,400 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,329,585 | 180,776 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $3,270,897 | 173,799 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,752,281 | 172,882 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,741,281 | 167,560 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,127,801 | 151,015 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,232,013 | 133,444 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,997,626 | 128,433 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,162,173 | 130,173 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,134,651 | 128,522 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,984,595 | 115,682 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $6,671,594 | 124,796 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $5,143,710 | 124,696 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,408,267 | 132,211 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,867,103 | 162,535 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||